Novartis Pharma, Mitsubishi Tanabe Pharma Revise Cooperation HMG-GoA Reductase Inhibitor Lochol(R).
Publication Date: 15-JAN-08
Publication Title: JCNN News Summaries
Format: Online
Company: Novartis Pharma AG

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Description

Tokyo, Japan, Jan 15, 2008 - (JCN) - Novartis Pharma K.K. and Mitsubishi Tanabe Pharma announced plans to rework threir cooperation on HMG-GoA reductase inhibitor Lochol(R) (generic name: fluvastatin sodium). Lochol is a hypercholesteremia treatment originally developed by Novartis Pharma AG.

Lochol was jointly developed in Japan by Novartis...

Access Full Article, Compliments of Goliath


More articles from JCNN News Summaries
Kissei Enters Development and Sales Agreement with Pneuma Partners LLC..., January 15, 2008

Looking for additional articles?
Click here to search our database of over 3 million articles.